Recombinant vaccine protects juvenile hybrid grouper, Epinephelus fuscoguttatus × Epinephelus lanceolatus, against infection by Vibrio alginolyticus

Vibrio alginolyticus has been recognized as one of the most significant bacterial diseases in grouper species. In this study, two outer membrane proteins of V. alginolyticus, the OmpK and OmpW, were considered for vaccine development, since both OmpK and OmpW were proven by previous studies to be pr...

Full description

Bibliographic Details
Main Authors: Rosli, Nehlah, Nawi, Mohd Firdaus, Nik Yusoff, Nik Haiha, Abd Karim, Murni Marlina, Saad, Mohd Zamri, Md Yasin, Ina Salwany
Format: Article
Published: Springer 2017
_version_ 1825932533376745472
author Rosli, Nehlah
Nawi, Mohd Firdaus
Nik Yusoff, Nik Haiha
Abd Karim, Murni Marlina
Saad, Mohd Zamri
Md Yasin, Ina Salwany
author_facet Rosli, Nehlah
Nawi, Mohd Firdaus
Nik Yusoff, Nik Haiha
Abd Karim, Murni Marlina
Saad, Mohd Zamri
Md Yasin, Ina Salwany
author_sort Rosli, Nehlah
collection UPM
description Vibrio alginolyticus has been recognized as one of the most significant bacterial diseases in grouper species. In this study, two outer membrane proteins of V. alginolyticus, the OmpK and OmpW, were considered for vaccine development, since both OmpK and OmpW were proven by previous studies to be promising vaccine candidates. Recombinant vaccines were constructed by cloning the OmpK and OmpW genes of V. alginolyticus into pET32 Ek/LIC vector and expressed in Escherichia coli. Fish were immunized with inactivated E. coli expressing the OMPs. Juvenile hybrid groupers, Epinephelus fuscoguttatus × Epinephelus lanceolatus, were divided into five groups of 150 fish per group. Group 1 was vaccinated IP with rOmpK while group 2 with rOmpW; group 3 was vaccinated with host E. coli BL21(DE3), group 4 with phosphate-buffered saline (PBS) only, and group 5 was the environmental control group. Each vaccination was carried out with 0.5 mL fish−1 vaccine and at 28 °C water temperature. Booster dose of respective vaccine was delivered on day 14, and all groups were challenged with 109 CFU mL−1 of live V. alginolyticus using intraperitoneal (IP) injection at 0.5 mL fish−1 on day 28. The relative percentage survival (RPS) was highest for rOmpK group at 100%, followed by rOmpW group at 63%, and E. coli BL21(DE3) group at 0%. The IgM antibody specific to V. alginolyticus was detected in the serum, in which both rOmpK and rOmpW vaccinated groups showed an increasing pattern in antibody level following vaccinations. The IgM against rOmpK showed significantly (p < 0.05) higher OD values than rOmpW at challenge on day 28 post vaccination. The results of this study suggest that rOmpK succeeded in providing excellent protection while the rOmpW succeeded in providing partial protection against infection by V. alginolyticus.
first_indexed 2024-03-06T09:43:30Z
format Article
id upm.eprints-62921
institution Universiti Putra Malaysia
last_indexed 2024-03-06T09:43:30Z
publishDate 2017
publisher Springer
record_format dspace
spelling upm.eprints-629212022-11-25T01:31:09Z http://psasir.upm.edu.my/id/eprint/62921/ Recombinant vaccine protects juvenile hybrid grouper, Epinephelus fuscoguttatus × Epinephelus lanceolatus, against infection by Vibrio alginolyticus Rosli, Nehlah Nawi, Mohd Firdaus Nik Yusoff, Nik Haiha Abd Karim, Murni Marlina Saad, Mohd Zamri Md Yasin, Ina Salwany Vibrio alginolyticus has been recognized as one of the most significant bacterial diseases in grouper species. In this study, two outer membrane proteins of V. alginolyticus, the OmpK and OmpW, were considered for vaccine development, since both OmpK and OmpW were proven by previous studies to be promising vaccine candidates. Recombinant vaccines were constructed by cloning the OmpK and OmpW genes of V. alginolyticus into pET32 Ek/LIC vector and expressed in Escherichia coli. Fish were immunized with inactivated E. coli expressing the OMPs. Juvenile hybrid groupers, Epinephelus fuscoguttatus × Epinephelus lanceolatus, were divided into five groups of 150 fish per group. Group 1 was vaccinated IP with rOmpK while group 2 with rOmpW; group 3 was vaccinated with host E. coli BL21(DE3), group 4 with phosphate-buffered saline (PBS) only, and group 5 was the environmental control group. Each vaccination was carried out with 0.5 mL fish−1 vaccine and at 28 °C water temperature. Booster dose of respective vaccine was delivered on day 14, and all groups were challenged with 109 CFU mL−1 of live V. alginolyticus using intraperitoneal (IP) injection at 0.5 mL fish−1 on day 28. The relative percentage survival (RPS) was highest for rOmpK group at 100%, followed by rOmpW group at 63%, and E. coli BL21(DE3) group at 0%. The IgM antibody specific to V. alginolyticus was detected in the serum, in which both rOmpK and rOmpW vaccinated groups showed an increasing pattern in antibody level following vaccinations. The IgM against rOmpK showed significantly (p < 0.05) higher OD values than rOmpW at challenge on day 28 post vaccination. The results of this study suggest that rOmpK succeeded in providing excellent protection while the rOmpW succeeded in providing partial protection against infection by V. alginolyticus. Springer 2017-06 Article PeerReviewed Rosli, Nehlah and Nawi, Mohd Firdaus and Nik Yusoff, Nik Haiha and Abd Karim, Murni Marlina and Saad, Mohd Zamri and Md Yasin, Ina Salwany (2017) Recombinant vaccine protects juvenile hybrid grouper, Epinephelus fuscoguttatus × Epinephelus lanceolatus, against infection by Vibrio alginolyticus. Aquaculture International, 25 (6). 2047 - 2059. ISSN 0967-6120; ESSN: 1573-143X https://link.springer.com/article/10.1007/s10499-017-0172-8 10.1007/s10499-017-0172-8
spellingShingle Rosli, Nehlah
Nawi, Mohd Firdaus
Nik Yusoff, Nik Haiha
Abd Karim, Murni Marlina
Saad, Mohd Zamri
Md Yasin, Ina Salwany
Recombinant vaccine protects juvenile hybrid grouper, Epinephelus fuscoguttatus × Epinephelus lanceolatus, against infection by Vibrio alginolyticus
title Recombinant vaccine protects juvenile hybrid grouper, Epinephelus fuscoguttatus × Epinephelus lanceolatus, against infection by Vibrio alginolyticus
title_full Recombinant vaccine protects juvenile hybrid grouper, Epinephelus fuscoguttatus × Epinephelus lanceolatus, against infection by Vibrio alginolyticus
title_fullStr Recombinant vaccine protects juvenile hybrid grouper, Epinephelus fuscoguttatus × Epinephelus lanceolatus, against infection by Vibrio alginolyticus
title_full_unstemmed Recombinant vaccine protects juvenile hybrid grouper, Epinephelus fuscoguttatus × Epinephelus lanceolatus, against infection by Vibrio alginolyticus
title_short Recombinant vaccine protects juvenile hybrid grouper, Epinephelus fuscoguttatus × Epinephelus lanceolatus, against infection by Vibrio alginolyticus
title_sort recombinant vaccine protects juvenile hybrid grouper epinephelus fuscoguttatus epinephelus lanceolatus against infection by vibrio alginolyticus
work_keys_str_mv AT roslinehlah recombinantvaccineprotectsjuvenilehybridgrouperepinephelusfuscoguttatusepinepheluslanceolatusagainstinfectionbyvibrioalginolyticus
AT nawimohdfirdaus recombinantvaccineprotectsjuvenilehybridgrouperepinephelusfuscoguttatusepinepheluslanceolatusagainstinfectionbyvibrioalginolyticus
AT nikyusoffnikhaiha recombinantvaccineprotectsjuvenilehybridgrouperepinephelusfuscoguttatusepinepheluslanceolatusagainstinfectionbyvibrioalginolyticus
AT abdkarimmurnimarlina recombinantvaccineprotectsjuvenilehybridgrouperepinephelusfuscoguttatusepinepheluslanceolatusagainstinfectionbyvibrioalginolyticus
AT saadmohdzamri recombinantvaccineprotectsjuvenilehybridgrouperepinephelusfuscoguttatusepinepheluslanceolatusagainstinfectionbyvibrioalginolyticus
AT mdyasininasalwany recombinantvaccineprotectsjuvenilehybridgrouperepinephelusfuscoguttatusepinepheluslanceolatusagainstinfectionbyvibrioalginolyticus